IHS Chemical Week

Regions :: India/Pakistan

Shasun gains FDA and Brazilian Anvisa approvals for Puducherry plant

12:10 PM MDT | July 17, 2013 | Natasha Alperowicz

Shasun Pharmaceuticals (Chennai, India), a leading producer of active pharmaceutical ingredients and formulations catering for global customers, says it completed the US FDA inspection during the last week in June to gain approval for certain products that have been commercially launched by its undisclosed customer in the United States. The inspection concluded that the facility, systems, and practices comply with FDA requirements. Shasun tells CW that the plant is based at Puducherry and is a formulation facility.   The plant has also undergone a Brazilian...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa